Posted by Chris on February 27, 1999, at 0:22:16
In reply to Skin Patch for ADs, posted by paul frank on February 25, 1999, at 20:12:04
Selegiline (l-deprenyl, Eldepryl), an MAOI approved by the FDA for Parkinson disease, is in phase III clinical trials. According to a NARSAD report it may be up to three years before it is widely available. Somerset Pharmaceuticals is conducting the trials for use in major depression. The NARSAD article quotes Dr. Alexander Bodkin, Director of McLean Hospital's Clinical Psychopharmacology Research Program and sounds quite positive. Recruitment for the trial apparently ended in Jan (>http://www.mhsource.com/advocacy/narsad/newmeds.html). I have been taking selegiline orally for the past five months and have found it helpful for my severe Bipolar II depression. Other ADs, including wellbutrin and Parnate were associated with cycling. The possible lack of dietary restrictions sound almost good to be true. Hope this helps.
>(National Alliance for Research on Schizophrenia & Depression
poster:Chris
thread:3245
URL: http://www.dr-bob.org/babble/19990201/msgs/3278.html